Eruptive Melanocytic Nevi without Any Trigger in a 5-Year-Old Healthy Girl

644 Ann Dermatol Received August 5, 2016, Revised September 7, 2016, Accepted for publication September 9, 2016 Corresponding author: Moon-Bum Kim, Department of Dermatology, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea. Tel: 82-51-240-7338, Fax: 82-51-245-9467, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology cause Hailey-Hailey disease. Nat Genet 2000;24:61-65. 2. Dobson-Stone C, Fairclough R, Dunne E, Brown J, Dissanayake M, Munro CS, et al. Hailey-Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol 2002;118:338-343. 3. Matsuda M, Hamada T, Numata S, Teye K, Okazawa H, Imafuku S, et al. Mutation-dependent effects on mRNA and protein expressions in cultured keratinocytes of Hailey-Hailey disease. Exp Dermatol 2014;23:514-516. 4. Btadini W, Abou Hassan OK, Saadeh D, Abbas O, Ballout F, Kibbi AG, et al. Identification of several mutations in ATP2C1 in Lebanese families: insight into the pathogenesis of HaileyHailey disease. PLoS One 2015;10:e0115530. 5. Kellermayer R, Szigeti R, Keeling KM, Bedekovics T, Bedwell DM. Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease. J Invest Dermatol 2006;126:229-231.